JMI Partner Matt Emery named to GrowthCap’s Top 25 Healthcare Investors of 2024

JMI Equity, a growth equity firm focused on investing in leading software companies, is pleased to announce that JMI Partner Matt Emery, has been recognized by GrowthCap as among the Top 25 Healthcare Investors of 2024.

To be selected, nominees must demonstrate expertise and success investing in healthcare, whether in healthcare software, healthcare services, medical technologies, biotechnology, the connected patient experience, or other related areas.  In addition, selected nominees provide unique strategic and/or operational value to the companies they invest in and have earned the respect of their peers in the industry.

Matt joined JMI in 2006 and is based in the San Diego office. He focuses on JMI’s investments in software and healthcare IT businesses. He currently oversees the investments or serves on the boards of CipherHealth, Clio, Jane Software, PointClickCare, and TimelyCare.

Disclaimer: GrowthCap is a leading growth capital research and advisory firm. The criteria considered for this award is determined by GrowthCap which compiles its annual list by speaking with investors, firms, portfolio companies, healthcare industry colleagues, and/or peers at other investment firms across industries, evaluating firm attributes through nomination submissions, reviewing ESG commitment, and studying investment performance to form a holistic view. The award is the subjective determination of the party conferring the award and not of JMI Equity. JMI Equity submitted a nomination to be considered for, and once selected, paid to be included on, and to promote inclusion on, this list. JMI Equity received this award in 2024. For more information about GrowthCap, please see their website at growthcapadvisory.com. JMI is not responsible for the contents of any third-party website and has not confirmed the accuracy of any information provided therein.